Trial intelligence / Profile preview

Simultaneous immunization with KLH (neo-antigen) and tetanus toxoid (recall antigen) in healthy volunteers

2017-000084-32Phase 4Completed

Sponsor
Centre for Human Drug Research
Start
Jan 2017
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of IMG KLH and tetanus toxoid in Healthy volunteer immunization (2 arms), sponsored by Centre for Human Drug Research. Started Jan 2017; status: completed.

02

Drugs

IMG KLHtetanus toxoid
03

Conditions

Healthy volunteer immunization

Beyond the preview

Go deeper on 2017-000084-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000084-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call